| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Azilsartan Impurity I |
阿齐沙坦杂质I |
1403474-78-1 |
详细
|
| Azilsartan Impurity 52 |
阿齐沙坦杂质 52 |
139481-38-2 |
详细
|
| Azilsartan Impurity I |
阿齐沙坦杂质I |
139481-33-7 |
详细
|
| Azilsartan Impurity N |
阿齐沙坦杂质N |
2244031-86-3 |
详细
|
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
(4-氯-7H-吡咯并[2,3-D]嘧啶-7-基)甲基特戊酸酯 |
1146629-75-5 |
详细
|
| bis(((R)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl) hydrogen phosphate |
特地唑胺杂质37 |
1256966-02-5 |
详细
|
| Dolutegravir Impurity 11 |
度鲁特韦杂质27 |
2227442-13-7 |
详细
|
| Azilsartan Impurity H |
阿齐沙坦杂质H |
1499167-72-4 |
详细
|
| N-((S)-10-formyl-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid |
|
74644-66-9 |
详细
|
| Azilsartan |
阿齐沙坦 |
147403-03-0 |
详细
|
| Azilsartan Impurity C |
阿齐沙坦杂质C |
1397836-49-5 |
详细
|
| Azilsartan Impurity 45 |
阿齐沙坦杂质45 |
136304-78-4 |
详细
|
| (R)-3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-5- (hydroxymethyl)oxazolidin-2-one |
特地唑胺杂质08 |
1771765-84-4 |
详细
|
| 2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2), (3S,4S)- |
(3S,4S)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine dihydrochloride
英文 |
2055761-19-6 |
详细
|
| Dolutegravir Impurity 16 |
多替拉韦杂质16 |
1357289-37-2 |
详细
|
| NA |
|
16963392-11-6 |
详细
|
| Rocuronium Bromide EP Impurity C |
罗库溴铵EP杂质C |
119302-86-2 |
详细
|
| Iguratimod Impurity |
艾拉莫德杂质 |
149436-41-9 |
详细
|
| Azilsartan Impurity O |
阿齐沙坦杂质O |
2171316-29-1 |
详细
|
| Azilsartan Impurity K |
阿齐沙坦杂质 K |
1442400-68-1 |
详细
|
| Aprepitant EP Impurity C |
阿瑞匹坦EP杂质C |
2348441-63-2 |
详细
|
| Folic Acid EP Impurity H |
叶酸EP杂质H |
2366274-27-1 |
详细
|
| Ruxolitinib Impurity 17 |
芦可替尼杂质17 |
2950130-23-9 |
详细
|
| Calcitriol EP Impurity A |
骨化三醇EP杂质A |
73837-24-8 |
详细
|
| Iguratimod Impurity |
艾拉莫德杂质 |
149457-03-4 |
详细
|
| (R)-(3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-2- oxooxazolidin-5-yl)methyl dihydrogen phosphate |
特地唑胺杂质09 |
1239662-47-5 |
详细
|
| Vecuronium Bromide Impurity 4 |
维库溴铵杂质H |
13522-24-2 |
详细
|
| Methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate |
2-[[(2'-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸甲酯 |
139481-28-0 |
详细
|
| Rocuronium Bromide EP Impurity B |
罗库溴铵EP杂质B |
122483-73-2 |
详细
|
| (5R)-3-[4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone |
特地唑胺杂质 |
1256966-04-7 |
详细
|
| Iguratimod Impurity |
艾拉莫德杂质 |
123662-92-0 |
详细
|
| Azilsartan Impurity 3 |
阿齐沙坦杂质3 |
1696392-12-7 |
详细
|
| Dolutegravir Impurity 3 |
度鲁特韦杂质 3 |
1973402-05-9 |
详细
|
| Tedizolid Ring Open Impurity |
特地唑胺异构体杂质 |
1239662-49-7 |
详细
|
| Dolutegravir Impurity 5 |
多替拉韦杂质5 |
1863916-88-4 |
详细
|
| (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide |
利伐沙班杂质I |
721401-53-2 |
详细
|
| Azilsartan Impurity M |
阿齐沙坦杂质M |
632322-61-3 |
详细
|
| Dolutegravir Enantiomer |
度鲁特韦对映异构体 |
1309560-49-3 |
详细
|
| Iguratimod Impurity |
艾拉莫德杂质 |
1179354-65-4 |
详细
|
| 3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile |
3-环戊基-3-[4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-1H-吡唑-1-基]丙腈 |
1153949-38-2 |
详细
|
| Rocuronium Bromide EP Impurity D |
罗库溴铵EP杂质D |
1190105-63-5 |
详细
|
| Iguratimod Impurity |
艾拉莫德杂质 |
123663-48-9 |
详细
|
| Azilsartan Impurity D |
阿奇沙坦杂质D |
1821386-21-3 |
详细
|
| Azilsartan Impurity 37 |
阿齐沙坦杂质37 |
147404-76-0 |
详细
|
| (2β,3α,5α,16β,17β)-2,16-Di-(1-piperidinyl)androstane-3,17-diol 3-Acetate |
维库溴铵杂质I |
53357-31-6 |
详细
|
| Dotiravir Impurity 8 |
度鲁特韦杂质8 |
1863916-87-3 |
详细
|
| Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) |
9-(4-甲氧基-2,3,6-三甲基苯基)-3,7-二甲基-2,4,6,8-丁烯酸 |
69427-46-9 |
详细
|